|
[1]
|
Mathieu E, Ritchie H, Rodés-Guirao L, Appel C, Giattino C, Hasell J, et al. Coronavirus pandemic (COVID-19) our world in data. 2020. https://ourworldindata.org/coronavirus. [2023-1-13].https://ourworldindata.org/coronavirus |
|
[2]
|
Zhang ZC, Hao M, Zhang XC, He YF, Chen XS, Taylor EW, et al. Potential of green tea EGCG in neutralizing SARS-CoV-2 Omicron variant with greater tropism toward the upper respiratory tract. Trends Food Sci Technol 2023;132:40-53. http://dx.doi.org/10.1016/j.jpgs.2022.12.012CrossRef
|
|
[3]
|
Higdon MM, Baidya A, Walter KK, Patel MK, Issa H, Espié E, et al. Duration of effectiveness of vaccination against COVID-19 caused by the omicron variant. Lancet Infect Dis 2022;22(8):1114-6. http://dx.doi.org/10.1016/S1473-3099(22)00409-1CrossRef
|
|
[4]
|
Feikin DR, Higdon MM, Abu-Raddad LJ, Andrews N, Araos R, Goldberg Y, et al. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression. Lancet 2022;399(10328):924-44. http://dx.doi.org/10.1016/S0140-6736(22)00152-0CrossRef
|
|
[5]
|
Ledford H. Do vaccines protect against long COVID? What the data say. Nature 2021;599(7886):546-8. http://dx.doi.org/10.1038/d41586-021-03495-2CrossRef
|
|
[6]
|
Yang JL, McClymont H, Wang LP, Vardoulakis S, Hu WB. Epidemic features of COVID-19 and potential impact of hospital strain during the omicron wave - Australia, 2022. China CDC Wkly 2023;5(7):165-9. http://dx.doi.org/10.46234/ccdcw2023.029CrossRef
|
|
[7]
|
Watson OJ, Barnsley G, Toor J, Hogan AB, Winskill P, Ghani AC. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Infect Dis 2022;22(9):1293-302. http://dx.doi.org/10.1016/S1473-3099(22)00320-6CrossRef
|
|
[8]
|
Leung K, Jit M, Leung GM, Wu JT. The allocation of COVID-19 vaccines and antivirals against emerging SARS-CoV-2 variants of concern in East Asia and Pacific region: A modelling study. Lancet Reg Health West Pac 2022;21:100389. http://dx.doi.org/10.1016/j.lanwpc.2022.100389CrossRef
|
|
[9]
|
WHO. COVAX: Working for global equitable access to COVID-19 vaccines. https://www.who.int/initiatives/act-accelerator/covax. [2023-1-13].https://www.who.int/initiatives/act-accelerator/covax |
|
[10]
|
Kunyenje CA, Chirwa GC, Mboma SM, Ng'ambi W, Mnjowe E, Nkhoma D, et al. COVID-19 vaccine inequity in African low-income countries. Front Public Health 2023;11:1087662. http://dx.doi.org/10.3389/fpubh.2023.1087662CrossRef
|